Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2019) 62 P72 | DOI: 10.1530/endoabs.62.P72

EU2019 Society for Endocrinology: Endocrine Update 2019 Poster Presentations (73 abstracts)

Challenges in managing a young lady with recurrent unexplained hypoglycaemia

Tim Robbins , Narasimha Murthy & Nitin Gholap


University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.


Case history: A 23-year-old Caucasian nurse presented with six months of frequent recurrent symptomatic hypoglycaemic episodes with capillary blood glucose ranging between 1.2 and 3.5 mmol/l and symptoms improving after a carbohydrate snack or a drink. The episodes were more likely to occur during fasting state and after excess physical activities. A careful history excluded intake of any off-prescription medications, dfrugs or psychosocial problem.

Investigations: FBC, U&E, LFTs, bone profile, prolactin, IGF-1, LH, FSH, free T4, TSH, random and 0900 h cortisol, short synacthen test, 72-hour fasting, 5 hour OGTT, mixed meal test, coeliac screening, plasm metanephrines, IGF1:IGF2 ratio, insulin antibodies, fasting gut peptides, amino acids carnitines, ammonia, lactate, glycogen storage disorder genetic testing. Urine metabolic and organic acid screening, 24-hour urine 5HIAA, sulphonylureas screening. MRI pancreas, small bowel, abdomen, neck. CT thorax.

Results and treatment: All above routine and other investigations, urine tests, pituitary hormone profile and radiological investigations were normal. During the first 72-hour fasting, she developed symptomatic hypoglycaemia (plasma glucose 1.8 mmol/l) and concomitant levels of insulin (10 mmol/l) and C-peptide (<94 pmol/l) were appropriately suppressed. Blood sulphonylurea screen during hypoglycaemia was negative. During the second 72-hour fasting, her lowest plasma glucose level was 2.3 mmol/l, and concomitant levels of insulin (11 mmo/l) and C-peptide (125 pmol/l) were appropriately supressed. Corresponding hydroxybutyrate levels were high >3000. IGF-2: IGF-1 ratio (4.0) and insulin antibodies (4.8 Mg/l (<5)) were normal. During the mixed meal test, her blood glucose was at its lowest (3.3 mmol/l) at 150 minutes post meal without any symptoms. A diagnosis of idiopathic hyperketotic hypoglycaemia resulting from some rare yet unidentified enzymatic defects in her glucose metabolism pathway was made. She has been enrolled in the 100,000-genome project. Despite a trial of dietary interventions she continued to suffer from hypoglycaemic episodes significantly affecting her work and quality of life. Therefore, oral hydrocortisone (total 20 mg a day) was initiated on a trial basis on which she showed a significant improvement.

Conclusions and points for discussion: Hypoglycaemic disorders are common especially in young women, where a common diagnosis is reactive hypoglycaemia. However, this case highlights the challenges in investigating and managing hypoglycaemia where a cause is not obvious after extensive investigations. When faced with any rare insulin-independent cause of hypoglycaemia a pragmatic approach to management with diet and, if necessary, pharmacotherapy is crucial in improving symptoms and quality of life.

Volume 62

Society for Endocrinology Endocrine Update 2019

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.